RxDoctor Payments Data

Lloyd Robinson, MD

Family Medicine · Memphis, TNNPI 1265534184

Payments from drug & device makers

$4,918in general payments, 2019–2025

Across 284 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Amarin Pharma, Inc.$635
  • Lilly USA, LLC$497
  • Merck$473
  • AbbVie$415
  • AstraZeneca$379
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$4,918100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,918 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$14,789
Medicare patients
73
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol16$14,419
EliquisApixaban12$12,196
Albuterol Sulfate HfaAlbuterol Sulfate26$968
Atorvastatin Calcium121$920
Omeprazole57$865
Gabapentin61$837
Amlodipine Besylate111$602
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide44$579
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$532
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide17$531
Metoprolol Tartrate31$524
Verapamil ErVerapamil Hcl14$501
Potassium Chloride26$463
Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril22$432
Alprazolam64$365

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$379$14,41916 claims
PfizerEliquis$44$12,19612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →